Cargando…
Assessing Genetic Variants in Matched Biocompartments From Patients With Serous Ovarian Cancer
The clinical use of molecular tumor profiling (MTP) is expanding and there is an increasing use of MTP data to manage patient care. At the University of Colorado, 18 patients were diagnosed with primary serous ovarian cancer between 9/2015 and 6/2019 and consented for banking and analysis of tumor,...
Autores principales: | Sanders, Brooke E., Ku, Lisa, Walker, Paul, Bitler, Benjamin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246573/ https://www.ncbi.nlm.nih.gov/pubmed/34169762 http://dx.doi.org/10.1177/15330338211027917 |
Ejemplares similares
-
Exosomes as versatile nanoscaled biocompartments in cancer therapy and/or resistance
por: Rahbar Saadat, Yalda, et al.
Publicado: (2022) -
Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome
por: Hargreaves, Patrick, et al.
Publicado: (2019) -
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
por: Wheeler, Lindsay J., et al.
Publicado: (2018) -
99529 The Role of ATF6-Mediated Signaling in PARP Inhibitor Resistant Ovarian Cancer
por: Alexandra,, et al.
Publicado: (2021) -
Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer
por: Létourneau, Isabelle J, et al.
Publicado: (2012)